Begin your TipRanks Premium journey today. PTC Therapeutics (PTCT) Company Description: PTC Therapeutics, Inc. is a biopharmaceutical company, which engages in the discovery and commercialization of ...
Begin your TipRanks Premium journey today. PTC Therapeutics (PTCT) Company Description: PTC Therapeutics, Inc. is a biopharmaceutical company, which engages in the discovery and commercialization of ...
PTC Therapeutics (PTCT) stock on watch as company receives FDA approval for gene therapy Kebilidi for AADC deficiency. Read ...
PTC Therapeutics' Kebilidi gains FDA accelerated approval as the first brain-administered gene therapy in the U.S. for AADC ...
2024 Total Revenue Guidance: Raised to $750 million to $800 million. PTC Therapeutics Inc (NASDAQ:PTCT) achieved total revenue of $197 million in the third quarter, with $124 million from the DMD ...
Nov 13 (Reuters) - The U.S. Food and Drug Administration approved PTC Therapeutics' (PTCT.O), opens new tab gene therapy to ...
Welcome to the PTC Third Quarter 2024 Financial Results Conference Call. At this time all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and ...
PTC Inc. Reports Strong Growth in 2024 PTC Announces Strong Growth and Stock Repurchase Plan PTC sees FY25 adjusted EPS $5.60-$6.30, consensus $5.83 PTC announces $2B share repurchase program PTC ...
Investing.com – U.S. stocks were lower after the close on Thursday, as losses in the Healthcare, Technology and Consumer Services sectors led shares lower. At the close in NYSE,... Investing.com ...
ROKA -13%.Now read: AcelRx: Ironically, I Misunderstood The... BySeeking Alpha • Sep 26, 2017 Investors shaken by PTC's briefing docs ahead of Ad Com for DMD candidate Translarna; shares down 14 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback